Dr. Alejandro Chade had a problem. All he needed was some ELP.Biotechnology developed by a University of Mississippi Medical Center team could become a new treatment for renal vascular disease (RVD). In a study published online in November by the Journal of the American Society for Nephrology, the work demonstrates how an elastin-like polypeptide (ELP) fused with vascular endothelial growth factor (VEGF) promotes blood vessel repair, formation, and function in damaged kidney tissues.“This is...
2500 North State Street
Jackson, MS 39216
General Information: 601-984-1000
Patient Appointments: 888-815-2005